Treatment of Hidradenitis Suppurativa with a blue light (415 nm) and red light(633 nm) combination PDT

Completed

• Conditions: acne inversa; hidradenitis suppurativa; 10014982

• Registration Number: NL-OMON31302
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 11

Inclusion Criteria

Suffering from hidradenitis suppurativa. 18-45 years old. In case of oral medication/ anticonceptives: use of at least 6 months and intention te continue use during study.

Exclusion Criteria

-Oral medication for HS in last 2 months
-In menopause or postmenopausal
-Intention to use anticonceptives
-Previous external or oral use of isotretinoine in last 6 months
-Oral/ local anti-inflammatory medication during the last 4 weeks
-Epilepsy
-Pregnancy, breastfeeding, intention to conceive
-Photosensitivity
-Use of photosensitive medication
-treatment for cancer in the past, history of skincancer, presence of premaligne lesions
-Use of anticoagulants, suffering from a clotting-disease.
-Surgical operations in the treatment areas in the past 6 months
-recently had PDT for HS
-Recent suntanning or planning to

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Reduction Sartorius score<br /><br>reduction unidimensional visual painscore</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Time to improvement individual laesions<br /><br>Time to improvement painscale scores<br /><br>Treatment experience<br /><br>satisfaction<br /><br>side effects<br /><br>visual improvements on photo's</p><br>